The Families Addressing Cancer Together Intervention for Parents With Cancer

Cancer Clinical Trial

— FACT  

Official title:

Families Addressing Cancer Together (FACT): A Pilot Randomized Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05377749
• Other study ID #: LCCC2150
• Secondary ID: 5K07CA218167
• Status: Completed
• Phase: N/A
• Start date: July 5, 2022
• Est. completion date: February 22, 2023

Study information

• Verified date: February 2024
• Source: UNC Lineberger Comprehensive Cancer Center
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The proposed pilot randomized controlled trial will test the FACT (Families Addressing Cancer Together) intervention designed to improve parents' confidence and ability to talk about their cancer with their minor children. We will enroll 40 patients with cancer who have a minor child to participate in this single site, 6-week study. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible and acceptable when compared with a wait-list control condition.

Description:

Parents with cancer are encouraged to be "honest and open" with their minor children about their illness. However, many lack access to professional support for their communication needs. Without this support, parents with cancer and their children experience avoidable psychosocial distress. In order to better support parental communication needs in cancer, psychosocial interventions that can be implemented across clinical practice settings are needed. To address this gap, we developed and pilot-tested FACT (Families Addressing Cancer Together) - a theory-guided, web-based psycho-educational intervention to help parents with cancer talk about their illness with their children in a developmentally appropriate way. The proposed pilot randomized controlled trial will test the feasibility and acceptability of the FACT intervention. We will enroll 40 patients with cancer who have a minor child to participate in this single site, 6-week study. The primary hypothesis being tested is that an intervention that assists parents with their communication needs with their children can be feasible and acceptable when compared with a wait-list control condition. We will also explore preliminary effects of the intervention on parental communication and psychological outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 46
• Est. completion date: February 22, 2023
• Est. primary completion date: February 22, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Informed consent reviewed and signed;
• Age equal to or above 18 years;
• Ability to understand and comply with study procedures;
• Able to complete all study measures and visits in English;
• Be a parent (defined as biological, adoptive, foster, or step-parent), kin caregiver (defined as a relative or someone with a significant emotional relationship who provides full-time care and nurturing of a child), or legal guardian of a child age 3 to 17 years of age who can speak and understand English;
• Have a diagnosis of Stage II-IV (or equivalent) invasive solid tumor not in surveillance or survivorship

Exclusion Criteria:

• Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes;
• Prior participation in the pilot trial or development and user testing protocol preliminary to this study;
• No current or expected contact with their child; or
• Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol.

Related Conditions & MeSH terms

• Cancer
• Communication
• Neoplasms
• Parent-Child Relations
• Parenting
• Parents

Intervention

Behavioral:
• FACT
Families Addressing Cancer Together (FACT) is a web-based intervention that provides tailored communication support for parents with cancer.

Locations

Country	Name	City	State
United States	Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill	Chapel Hill	North Carolina

Sponsors (3)

Lead Sponsor	Collaborator
UNC Lineberger Comprehensive Cancer Center	National Cancer Institute (NCI), National Institute of Allergy and Infectious Diseases (NIAID)

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Families Addressing Cancer Together (FACT) Satisfaction Scale	Acceptability was measured by the FACT satisfaction scale in the intervention group using the study-specific, 6-item FACT satisfaction scale. The total score range is 0-18 with higher scores indicating more satisfaction.	3 weeks
Primary	Acceptability as Measured by FACT Satisfaction Scale	Satisfaction with FACT will be measured in the intervention group using the study-specific, 6-item FACT satisfaction scale. Total score range is 0-18 with higher scores indicating more satisfaction.	6 weeks
Primary	Acceptability as Assessed by a Semi-structured, Post-intervention Interview	Satisfaction with FACT will be assessed via semi-structured, post-intervention interviews and analyzed via content analysis.	6 weeks
Secondary	Recruitment Feasibility as Measured by Percentage of Eligible Patients Who Consent to Study Participation	Percentage of approached patients who meet study eligibility criteria who enroll (provide informed consent) in the study.	6 weeks
Secondary	Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey	Feasibility of participant retention as measured by the percentage of participants who complete at least one study survey, at the 3-week time point.	3 weeks
Secondary	Feasibility of Participant Retention as Measured by Percentage of Participants Who Complete Survey Assessments at 6 Weeks.	Percentage of enrolled participants who complete at least one study survey (any) at the 6-week time point.	6 weeks
Secondary	Change From Baseline Communication Self-efficacy Using the CSES	Change in parental communication self-efficacy will be measured using an adapted version of the Communication Self-Efficacy Scale (CSES). The 9-item CSES measures parental communication self-efficacy on a visual analogue scale, with a total score range of 0 to 100, with higher scores meaning more self-efficacy.	Baseline, 3 weeks
Secondary	Change From Baseline Communication Self-efficacy Using the CSES	Change in parental communication self-efficacy will be measured using an adapted version of the Communication Self-Efficacy Scale (CSES). The 9-item CSES measures parental communication self-efficacy on a visual analogue scale, with a total score range of 0 to 100, with higher scores meaning more self-efficacy.	Baseline, 6 weeks